ScholarWorks@Gyeongsang National University: Browsing ScholarWorks

Browsing by Lee, SoohyeonAuthor

Showing results 1 to 3 of 3

SCIESCOPUS

Korean Precision Medicine Networking Group study of molecular profiling guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) II (KCSG AL 22-09)

Kim, Sun Young; Kim, Jee Hyun; Kim, Tae-Yong; Park, Sook Ryun; Yoon, Shinkyo; Lee, Soohyeon; Lee, Se-Hoon; Kim, Tae Min; Han, Sae-Won; Yun, Hongseok, et al.

ArticleIssue Date2023CitationJournal of Clinical Oncology, v.41, no.16PublisherAmerican Society of Clinical Oncology

SCIESCOPUS

Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09 open access

Kim, Sun Young; Kim, Jee Hyun; Kim, Tae-Yong; Park, Sook Ryun; Yoon, Shinkyo; Lee, Soohyeon; Lee, Se-Hoon; Kim, Tae Min; Han, Sae-Won; Kim, Hye Ryun, et al.

ArticleIssue Date2024CitationBMC Cancer, v.24, no.1PublisherBioMed Central

SCIESCOPUS

Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen

Beom, Seung-Hoon; Kim, Jong Gwang; Baik, Seung Hyuk; Shin, Seong Hoon; Park, Inkeun; Park, Young Suk; Lee, Myung-Ah; Lee, Soohyeon; Jeon, So-Yeon; Han, Sae-Won, et al.

ArticleIssue Date2023CitationJournal of Cancer Research and Clinical Oncology, v.149, no.3, pp 1131 - 1143PublisherSpringer Verlag

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0533

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Lee, SoohyeonAuthor

BROWSE